Characterization of Potential Biomarkers of Eye Disease and Vision

Eye Disease Clinical Trial

— EYE-MARKER  

Official title:

Characterization of Potential Biomarkers of Eye Disease and Vision Loss.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02500862
• Other study ID #: 4C-2015-08
• Status: Recruiting
• Start date: September 2015
• Est. completion date: December 2026

Study information

• Verified date: July 2023
• Source: Association for Innovation and Biomedical Research on Light and Image
• Contact: José G Cunha-Vaz, PhD
• Phone: +351239480103
• Email: jcv[@]aibili.pt
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI

Description:

This is a registry study. Only patients followed under the clinical practice at AIBILI Clinical Trial Centre, and with a signed informed consent form will be included.

Based on the clinical information collected under the clinical practice, and based on patients' characteristics, scientific questions will be raised and data will be collected and analysed accordingly.

Any procedure performed under clinical practice that may allow for the characterization of the disease and/or for the identification of potential biomarkers will be collected and analysed.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: December 2026
• Est. primary completion date: December 2026
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Any patient followed under the normal clinical practice at AIBILI Clinical Trial Centre, and with a AIBILI signed informed consent form for data collection, Imp. 11-7-2 "Consentimento Informado para tratamento de dados".

Exclusion criteria:

• None

Related Conditions & MeSH terms

• Eye Disease
• Eye Diseases

Locations

Country	Name	City	State
Portugal	CEC	Coimbra

Sponsors (1)

Lead Sponsor	Collaborator
Association for Innovation and Biomedical Research on Light and Image

Country where clinical trial is conducted

Portugal, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI.		10 years